Jóhannes Reynisson

4.6k total citations
154 papers, 3.7k citations indexed

About

Jóhannes Reynisson is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Jóhannes Reynisson has authored 154 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Molecular Biology, 81 papers in Organic Chemistry and 35 papers in Oncology. Recurrent topics in Jóhannes Reynisson's work include Cancer therapeutics and mechanisms (38 papers), Synthesis and biological activity (22 papers) and Synthesis and Biological Evaluation (20 papers). Jóhannes Reynisson is often cited by papers focused on Cancer therapeutics and mechanisms (38 papers), Synthesis and biological activity (22 papers) and Synthesis and Biological Evaluation (20 papers). Jóhannes Reynisson collaborates with scholars based in New Zealand, United Kingdom and Russia. Jóhannes Reynisson's co-authors include Steen Steenken, Euphemia Leung, Amin Mirza, David Barker, Ayesha Zafar, Константин П. Волчо, Olga I. Lavrik, Нариман Ф. Салахутдинов, Leukothea Ioakimidis and Saira Naeem and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Jóhannes Reynisson

152 papers receiving 3.7k citations

Peers

Countries citing papers authored by Jóhannes Reynisson

Since Specialization

Citations

This map shows the geographic impact of Jóhannes Reynisson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jóhannes Reynisson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jóhannes Reynisson more than expected).

Fields of papers citing papers by Jóhannes Reynisson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jóhannes Reynisson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jóhannes Reynisson. The network helps show where Jóhannes Reynisson may publish in the future.

Co-authorship network of co-authors of Jóhannes Reynisson

This figure shows the co-authorship network connecting the top 25 collaborators of Jóhannes Reynisson. A scholar is included among the top collaborators of Jóhannes Reynisson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jóhannes Reynisson. Jóhannes Reynisson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Thieno[2,3-b]pyridines as a Novel Strategy Against Cervical Cancer: Mechanistic Insights and Therapeutic Potential 2025 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), Ivana Novak, (unknown), Lisa I. Pilkington, (unknown), David Barker, Jóhannes Reynisson, Vedrana Čikeš Čulić	1
2	Accessing Active Fragments for Drug Discovery Utilising Nitroreductase Biocatalysis 2024 ·ChemBioChem ·(unknown), (unknown), (unknown), Alec Jenkins, Jóhannes Reynisson, Anja Winter, Sebastian C. Cosgrove	0
3	Sulfide, Sulfoxide, and Sulfone Derivatives of Usnic Acid as Inhibitors of Human TDP1 and TDP2 Enzymes 2024 ·Chemistry ·(unknown), (unknown), Nadezhda S. Dyrkheeva, (unknown), (unknown), (unknown), Rashid O. Anarbaev, (unknown), (unknown), A. D. M. Curtis, Olga A. Luzina, Константин П. Волчо, Нариман Ф. Салахутдинов, Olga I. Lavrik, Jóhannes Reynisson	0
4	Novel TDP1 Inhibitors: Disubstituted Thiazolidine-2,4-Diones Containing Monoterpene Moieties 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), Nadezhda S. Dyrkheeva, Alexandra L. Zakharenko, (unknown), Jóhannes Reynisson, (unknown), Olga A. Luzina, Константин П. Волчо, Нариман Ф. Салахутдинов, Olga I. Lavrik	3
5	Latonduine-1-Amino-Hydantoin Hybrid, Triazole-Fused Latonduine Schiff Bases and Their Metal Complexes: Synthesis, X-ray and Electron Diffraction, Molecular Docking Studies and Antiproliferative Activity 2023 ·Inorganics ·(unknown), Tim Gruene, Alexander Roller, Sandra Aranđelović, Jóhannes Reynisson, Vladimir B. Arion	4
6	Indolo[2,3-e]benzazocines and indolo[2,3-f]benzazonines and their copper(ii) complexes as microtubule destabilizing agents 2023 ·Dalton Transactions ·(unknown), Orsolya Dömötör, (unknown), Gabriella Spengler, Jóhannes Reynisson, (unknown), Gavin J. Miller, Éva A. Enyedy, Ruoli Bai, Ernest Hamel, Vladimir B. Arion	2
7	Validating TDP1 as an Inhibition Target for the Development of Chemosensitizers for Camptothecin-Based Chemotherapy Drugs 2021 ·Oncology and Therapy ·Euphemia Leung, (unknown), Jennifer A. Hollywood, Ayesha Zafar, Petr Tomek, David Barker, Lisa I. Pilkington, (unknown), Ries J. Langley, Nuala A. Helsby, C.J. Squire, Bruce C. Baguley, William A. Denny, Jóhannes Reynisson, Ivanhoe K. H. Leung	14
8	Author Correction: Glycosphingolipid expression at breast cancer stem cells after novel thieno[2,3-b]pyridine anticancer compound treatment 2021 ·Scientific Reports ·(unknown), Anita Markotić, (unknown), (unknown), Lisa I. Pilkington, Jóhannes Reynisson, Vedrana Čikeš Čulić	1
9	Improving the solubility of anti-proliferative thieno[2,3-b]quinoline-2-carboxamides 2021 ·Bioorganic & Medicinal Chemistry ·(unknown), (unknown), (unknown), Jóhannes Reynisson, Euphemia Leung, Lisa I. Pilkington, David Barker	7
10	Deoxycholic acid as a molecular scaffold for tyrosyl-DNA phosphodiesterase 1 inhibition: A synthesis, structure–activity relationship and molecular modeling study 2020 ·Steroids ·Oksana V. Salomatina, (unknown), Alexandra L. Zakharenko, Olga D. Zakharova, Arina A. Chepanova, Nadezhda S. Dyrkheeva, Н. И. Комарова, Jóhannes Reynisson, Rashid O. Anarbaev, Нариман Ф. Салахутдинов, Olga I. Lavrik, Константин П. Волчо	25
11	Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topoteсan on in vivo tumor models 2018 ·European Journal of Medicinal Chemistry ·(unknown), Olga A. Luzina, D. N. Sokolov, В. И. Каледин, В. П. Николин, Н. А. Попова, (unknown), Olga D. Zakharova, Arina A. Chepanova, Ayesha Zafar, Jóhannes Reynisson, Euphemia Leung, Ivanhoe K. H. Leung, Константин П. Волчо, Нариман Ф. Салахутдинов, Olga I. Lavrik	64
12	Development of NMR and thermal shift assays for the evaluation ofMycobacterium tuberculosisisocitrate lyase inhibitors 2017 ·MedChemComm ·Ram Prasad Bhusal, Krunal Patel, (unknown), (unknown), Ghader Bashiri, Jóhannes Reynisson, Jonathan Sperry, Ivanhoe K. H. Leung	12
13	Thieno[2,3-b]pyridine derivatives are potent anti-platelet drugs, inhibiting platelet activation, aggregation and showing synergy with aspirin 2017 ·European Journal of Medicinal Chemistry ·Naif K. Binsaleh, (unknown), Kathryn A. Whitehead, (unknown), Jóhannes Reynisson, Lisa I. Pilkington, David Barker, Sarah Jones, Nina Dempsey‐Hibbert	32
14	Hydration Free Energy as a Molecular Descriptor in Drug Design: A Feasibility Study 2016 ·Molecular Informatics ·Ayesha Zafar, Jóhannes Reynisson	24
15	Sorption and biodegradation of organic micropollutants during river bank filtration: A laboratory column study 2013 ·Water Research ·C. Bertelkamp, Julien Reungoat, Emile Cornelissen, Naresh Singhal, Jóhannes Reynisson, (unknown), Jan Peter van der Hoek, A.R.D. Verliefde	147
16	DFT calculations on the deprotonation site of the one-electron oxidised guanine–cytosine base pair 2010 ·Physical Chemistry Chemical Physics ·Steen Steenken, Jóhannes Reynisson	19
17	Structure-based design of imidazo[1,2-a]pyrazine derivatives as selective inhibitors of Aurora-A kinase in cells 2010 ·Bioorganic & Medicinal Chemistry Letters ·Nathalie Bouloc, Jonathan M. Large, Magda Kosmopoulou, Chongbo Sun, Amir Faisal, Mizio Matteucci, Jóhannes Reynisson, Nathan J. Brown, Butrus Atrash, Julian Blagg, Edward McDonald, Spiros Linardopoulos, Richard Bayliss, Vassilios Bavetsias	27
18	Known drug space as a metric in exploring the boundaries of drug-like chemical space 2009 ·European Journal of Medicinal Chemistry ·Amin Mirza, (unknown), Jóhannes Reynisson	27
19	Mutagenic potential of nitrenium ions of nitrobenzanthrones: Correlation between theory and experiment 2008 ·Environmental and Molecular Mutagenesis ·Jóhannes Reynisson, Marie Stiborová, Václav Martínek, Gonçalo Gamboa da Costa, David H. Phillips, Volker M. Arlt	19
20	Investigation of the incidence of “undesirable” molecular moieties for high-throughput screening compound libraries in marketed drug compounds 2008 ·European Journal of Medicinal Chemistry ·Peter Axerio-Cilies, (unknown), Amin Mirza, Jóhannes Reynisson	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact